(Q37947911)

25 August 2017

title

Response to anti-angiogenesis: an ever changing feature (English)

1 reference

25 August 2017

Francesco Bertolini

1

1 reference

25 August 2017

publication date

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

20 Suppl 3

1 reference

25 August 2017

page(s)

S61-2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

25 August 2017

1 reference

7 January 2021

Biomarkers of response and resistance to antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

Circulating endothelial cells. Biomarker of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

Cellular and soluble markers of tumor angiogenesis: from patient selection to the identification of the most appropriate postresistance therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

Bone marrow derived cells in tumor angiogenesis and growth: are they the good, the bad or the evil?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

ALK1 signaling regulates early postnatal lymphatic vessel development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970296-X

7 January 2021

10.1016/S0960-9776(11)70296-X

Identifiers

DOI

1 reference

25 August 2017

1 reference